The specific binding of [3H]EO-122, a radiolabeled class I antiarrhythmic drug to rat heart membranes

Edna Oppenheimer, Hamutal Meiri, Yaacov Ori

Research output: Contribution to journalArticlepeer-review

Abstract

[3H]EO-122, a radiolabeled class I antiarrhythmic drug, has been used to characterize a new specific binding system to rat heart membranes. The binding is saturable and competitive with unlabeled EO-122 and other antiarrhythmic drugs. In this system, [3H]EO-122 binds to two sites. Site A with an apparent Kd of 33.5 ± 1.5 nm, Bmax of 1.05 ± 0.15 pmol/mg protein and Hill coefficient nH = 4. Site B with an apparent Kd of 233 ± 25 nm, Bmax equals 5.7 ± 0.61 pmol/mg proteins and nH = 6. The binding to site B indicates that this site is pharmacologically relevant to known class IA antiarrhythmic drugs such as quinidine and procainamide. Lidocaine (class IB) does not interact with this site. Interpretation of the high Hill coefficient suggests that the binding of an antiarrhythmic drug to its pharmacologically relevant binding site exposes additional binding sites and/or modulates the affinity of adjacent binding sites.

Original languageEnglish
Pages (from-to)223-230
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume21
Issue number2
DOIs
StatePublished - Feb 1989

Keywords

  • Antiarrhythmic drugs
  • Antiarrhythmic receptor
  • Class I
  • Radioreceptor assay
  • [H]EO-122

Fingerprint

Dive into the research topics of 'The specific binding of [3H]EO-122, a radiolabeled class I antiarrhythmic drug to rat heart membranes'. Together they form a unique fingerprint.

Cite this